Severin Rodler

17PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersRadiation therapyReinforcement learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 16, 2024
Effects of Intraoperative Opioid Use and a Combined Anesthesia Protocol in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder-A Single-Center Experience.

Julian Marcon, Fatima Yefsah, Gerald B Schulz

|Jun 27, 2024
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology Center.

Severin Rodler, Can Aydogdu, Isabel Brinkmann

|Apr 27, 2024
The Vanishing Clinical Value of PD-L1 Status as a Predictive Biomarker in the First-Line Treatment of Urothelial Carcinoma of the Bladder.

Alexander Tamalunas, Can Aydogdu, Lena M Unterrainer

|Apr 18, 2024
Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy.

Severin Rodler, Dina Danninger, Lennert Eismann

|Nov 14, 2023
Can the Abdominal Aortic Atherosclerotic Plaque Index Predict Functional Outcomes after Robot-Assisted Partial Nephrectomy?

Alessandro Veccia, Emanuele Serafin, Alessandro Tafuri

|Oct 14, 2023
Artificial Intelligence in Surgical Training for Kidney Cancer: A Systematic Review of the Literature.

Natali Rodriguez Peñaranda, Ahmed Eissa, Stefania Ferretti

Pageof 3

Frequent Collaborators

5 joint publications

Giovanni Enrico Cacciamani

5 joint publications

Stefano Puliatti

5 joint publications

Juan Gómez Rivas

4 joint publications

Alexander Buchner